MedPacto, Inc. (KOSDAQ:235980)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,850.00
+65.00 (2.33%)
Sep 1, 2026, 3:30 PM KST

MedPacto Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-14,139-12,811-20,140-35,325-35,753-17,040
Depreciation & Amortization
1,0811,1561,5421,8331,8661,723
Loss (Gain) From Sale of Assets
-0.123.57-5.93--
Loss (Gain) From Sale of Investments
-483.66-219.96-554.71-350.51-1,018-627.44
Loss (Gain) on Equity Investments
32.68267.33452.51390.44525.38361.1
Stock-Based Compensation
1,1521,057697.51,0402,3752,745
Provision & Write-off of Bad Debts
-49.43--9.1-5.9--
Other Operating Activities
392.53167.05-222.66,305141.08-11,453
Change in Accounts Receivable
-248.73-1,665----
Change in Inventory
-280.9-646.15----
Change in Accounts Payable
-5.6173.35----
Change in Other Net Operating Assets
368.16-792.111,676-193.162,249-861.82
Operating Cash Flow
-12,181-13,390-16,559-26,301-29,614-25,153
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-97.72-91.25-313.89-100.64-877.63-756.56
Sale (Purchase) of Intangibles
-143.3-151.84-8.78-72.27-47.4-152.31
Investment in Securities
-2,75211,988-39,91596,94926,769-76,777
Other Investing Activities
-100-100-0-249.88-80.91-80.24
Investing Cash Flow
-3,40111,024-40,23796,52625,763-77,766

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---1,000-35.49
Long-Term Debt Issued
-----70,000
Total Debt Issued
---1,000-70,035
Short-Term Debt Repaid
----1,000--35.49
Long-Term Debt Repaid
--635.09-843.82-70,816-503.18-485.19
Total Debt Repaid
-646.53-635.09-843.82-71,816-503.18-520.69
Net Debt Issued (Repaid)
-646.53-635.09-843.82-70,816-503.1869,515
Issuance of Common Stock
---72,8443,4011,974
Other Financing Activities
----15.02-34
Financing Cash Flow
-646.53-635.09-843.822,0142,898101,523

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
26.11-10.9245.575.9219.59-2.78
Net Cash Flow
-16,202-3,012-57,59572,244-933.04-1,399

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12,278-13,481-16,873-26,402-30,491-25,909
Free Cash Flow Growth
------
Free Cash Flow Margin
-245.83%-345.80%----
Free Cash Flow Per Share
-358.47-393.32-500.99-1244.33-916.79-1265.52
Levered Free Cash Flow
-8,383-10,491-11,213-20,379-21,300-23,447
Unlevered Free Cash Flow
-8,303-10,418-11,155-20,070-15,288-18,592

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
---1,418--
Cash Income Tax Paid
--116.11138.25-124.39123.19100.05
Change in Working Capital
-167.08-3,0301,676-193.162,249-861.82